Cameron A Schmidt1, Terence E Ryan1, Chien-Te Lin1, Melissa M R Inigo1, Tom D Green1, Jeffrey J Brault2, Espen E Spangenburg1, Joseph M McClung3. 1. Department of Physiology, East Carolina University, Greenville, NC; Diabetes and Obesity Institute, Brody School of Medicine, East Carolina University, Greenville, NC. 2. Diabetes and Obesity Institute, Brody School of Medicine, East Carolina University, Greenville, NC; Department of Kinesiology, East Carolina University, Greenville, NC. 3. Department of Physiology, East Carolina University, Greenville, NC; Diabetes and Obesity Institute, Brody School of Medicine, East Carolina University, Greenville, NC. Electronic address: mcclungj@ecu.edu.
Abstract
OBJECTIVE: Reduced skeletal muscle mitochondrial function might be a contributing mechanism to the myopathy and activity based limitations that typically plague patients with peripheral arterial disease (PAD). We hypothesized that mitochondrial dysfunction, myofiber atrophy, and muscle contractile deficits are inherently determined by the genetic background of regenerating ischemic mouse skeletal muscle, similar to how patient genetics affect the distribution of disease severity with clinical PAD. METHODS: Genetically ischemia protected (C57BL/6) and susceptible (BALB/c) mice underwent either unilateral subacute hind limb ischemia (SLI) or myotoxic injury (cardiotoxin) for 28 days. Limbs were monitored for blood flow and tissue oxygen saturation and tissue was collected for the assessment of histology, muscle contractile force, gene expression, mitochondrial content, and respiratory function. RESULTS: Despite similar tissue O2 saturation and mitochondrial content between strains, BALB/c mice suffered persistent ischemic myofiber atrophy (55.3% of C57BL/6) and muscle contractile deficits (approximately 25% of C57BL/6 across multiple stimulation frequencies). SLI also reduced BALB/c mitochondrial respiratory capacity, assessed in either isolated mitochondria (58.3% of C57BL/6 at SLI on day (d)7, 59.1% of C57BL/6 at SLI d28 across multiple conditions) or permeabilized myofibers (38.9% of C57BL/6 at SLI d7; 76.2% of C57BL/6 at SLI d28 across multiple conditions). SLI also resulted in decreased calcium retention capacity (56.0% of C57BL/6) in BALB/c mitochondria. Nonischemic cardiotoxin injury revealed similar recovery of myofiber area, contractile force, mitochondrial respiratory capacity, and calcium retention between strains. CONCLUSIONS: Ischemia-susceptible BALB/c mice suffered persistent muscle atrophy, impaired muscle function, and mitochondrial respiratory deficits during SLI. Interestingly, parental strain susceptibility to myopathy appears specific to regenerative insults including an ischemic component. Our findings indicate that the functional deficits that plague PAD patients could include mitochondrial respiratory deficits genetically inherent to the regenerating muscle myofibers.
OBJECTIVE: Reduced skeletal muscle mitochondrial function might be a contributing mechanism to the myopathy and activity based limitations that typically plague patients with peripheral arterial disease (PAD). We hypothesized that mitochondrial dysfunction, myofiber atrophy, and muscle contractile deficits are inherently determined by the genetic background of regenerating ischemicmouse skeletal muscle, similar to how patient genetics affect the distribution of disease severity with clinical PAD. METHODS: Genetically ischemia protected (C57BL/6) and susceptible (BALB/c) mice underwent either unilateral subacute hind limb ischemia (SLI) or myotoxic injury (cardiotoxin) for 28 days. Limbs were monitored for blood flow and tissue oxygen saturation and tissue was collected for the assessment of histology, muscle contractile force, gene expression, mitochondrial content, and respiratory function. RESULTS: Despite similar tissue O2 saturation and mitochondrial content between strains, BALB/c mice suffered persistent ischemic myofiber atrophy (55.3% of C57BL/6) and muscle contractile deficits (approximately 25% of C57BL/6 across multiple stimulation frequencies). SLI also reduced BALB/c mitochondrial respiratory capacity, assessed in either isolated mitochondria (58.3% of C57BL/6 at SLI on day (d)7, 59.1% of C57BL/6 at SLI d28 across multiple conditions) or permeabilized myofibers (38.9% of C57BL/6 at SLI d7; 76.2% of C57BL/6 at SLI d28 across multiple conditions). SLI also resulted in decreased calcium retention capacity (56.0% of C57BL/6) in BALB/c mitochondria. Nonischemic cardiotoxin injury revealed similar recovery of myofiber area, contractile force, mitochondrial respiratory capacity, and calcium retention between strains. CONCLUSIONS:Ischemia-susceptible BALB/c mice suffered persistent muscle atrophy, impaired muscle function, and mitochondrial respiratory deficits during SLI. Interestingly, parental strain susceptibility to myopathy appears specific to regenerative insults including an ischemic component. Our findings indicate that the functional deficits that plague PAD patients could include mitochondrial respiratory deficits genetically inherent to the regenerating muscle myofibers.
Authors: Joseph M McClung; Timothy J McCord; Sehoon Keum; Soraya Johnson; Brian H Annex; Douglas A Marchuk; Christopher D Kontos Journal: Am J Pathol Date: 2012-03-21 Impact factor: 4.307
Authors: Zhen Yan; Sangdun Choi; Xuebin Liu; Mei Zhang; Jeoffrey J Schageman; Sun Young Lee; Rebecca Hart; Ling Lin; Frederick A Thurmond; R Sanders Williams Journal: J Biol Chem Date: 2002-12-10 Impact factor: 5.157
Authors: M R McGuigan; R Bronks; R U Newton; M J Sharman; J C Graham; D V Cody; W J Kraemer Journal: Med Sci Sports Exerc Date: 2001-12 Impact factor: 5.411
Authors: Christopher G R Perry; Daniel A Kane; Chien-Te Lin; Rachel Kozy; Brook L Cathey; Daniel S Lark; Constance L Kane; Patricia M Brophy; Timothy P Gavin; Ethan J Anderson; P Darrell Neufer Journal: Biochem J Date: 2011-07-15 Impact factor: 3.857
Authors: Iraklis I Pipinos; Stanley A Swanson; Zhen Zhu; Aikaterini A Nella; Dustin J Weiss; Tanuja L Gutti; Rodney D McComb; B Timothy Baxter; Thomas G Lynch; George P Casale Journal: Am J Physiol Regul Integr Comp Physiol Date: 2008-05-14 Impact factor: 3.619
Authors: Mary M McDermott; Frederick Hoff; Luigi Ferrucci; William H Pearce; Jack M Guralnik; Lu Tian; Kiang Liu; Joseph R Schneider; Leena Sharma; Jin Tan; Michael H Criqui Journal: J Am Geriatr Soc Date: 2007-03 Impact factor: 5.562
Authors: Joseph M McClung; Timothy J McCord; Terence E Ryan; Cameron A Schmidt; Tom D Green; Kevin W Southerland; Jessica L Reinardy; Sarah B Mueller; Talaignair N Venkatraman; Christopher D Lascola; Sehoon Keum; Douglas A Marchuk; Espen E Spangenburg; Ayotunde Dokun; Brian H Annex; Christopher D Kontos Journal: Circulation Date: 2017-04-25 Impact factor: 29.690
Authors: Michael D Tarpey; Adam J Amorese; Nicholas P Balestrieri; Kelsey H Fisher-Wellman; Espen E Spangenburg Journal: J Biol Chem Date: 2019-11-05 Impact factor: 5.157
Authors: Michael D Tarpey; Ana P Valencia; Kathryn C Jackson; Adam J Amorese; Nicholas P Balestrieri; Randall H Renegar; Stephen J P Pratt; Terence E Ryan; Joseph M McClung; Richard M Lovering; Espen E Spangenburg Journal: J Physiol Date: 2018-12-16 Impact factor: 5.182
Authors: Ahmed Ismaeel; Emma Fletcher; Dimitrios Miserlis; Marissa Wechsler; Evlampia Papoutsi; Gleb Haynatzki; Robert S Smith; William T Bohannon; Panagiotis Koutakis Journal: Transl Res Date: 2022-03-12 Impact factor: 10.171
Authors: Cameron A Schmidt; Adam J Amorese; Terence E Ryan; Emma J Goldberg; Michael D Tarpey; Thomas D Green; Reema R Karnekar; Dean J Yamaguchi; Espen E Spangenburg; Joseph M McClung Journal: Am J Pathol Date: 2018-02-16 Impact factor: 4.307
Authors: Terence E Ryan; Dean J Yamaguchi; Cameron A Schmidt; Tonya N Zeczycki; Saame Raza Shaikh; Patricia Brophy; Thomas D Green; Michael D Tarpey; Reema Karnekar; Emma J Goldberg; Genevieve C Sparagna; Maria J Torres; Brian H Annex; P Darrell Neufer; Espen E Spangenburg; Joseph M McClung Journal: JCI Insight Date: 2018-11-02
Authors: Michael D Tarpey; Adam J Amorese; Nicholas P Balestrieri; Terence E Ryan; Cameron A Schmidt; Joseph M McClung; Espen E Spangenburg Journal: Skelet Muscle Date: 2018-04-17 Impact factor: 4.912
Authors: Brittany C Collins; Tara L Mader; Christine A Cabelka; Melissa R Iñigo; Espen E Spangenburg; Dawn A Lowe Journal: J Appl Physiol (1985) Date: 2018-01-18
Authors: Jon Stavres; Jianli Wang; Christopher T Sica; Cheryl Blaha; Michael Herr; Samuel Pai; Aimee Cauffman; Jeffrey Vesek; Qing X Yang; Lawrence I Sinoway Journal: Eur J Appl Physiol Date: 2021-06-09 Impact factor: 3.078
Authors: Terence E Ryan; Cameron A Schmidt; Thomas D Green; Espen E Spangenburg; P Darrell Neufer; Joseph M McClung Journal: Diabetes Date: 2016-06-09 Impact factor: 9.461